13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label …
SA Silfverdal, CE Flodmark, L Rombo, SP Tansey… - Vaccine, 2013 - Elsevier
BACKGROUND: As 13-valent pneumococcal conjugate vaccine (PCV13) is introduced,
children who began vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) may …
children who began vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) may …
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants
E Grimprel, F Laudat, S Patterson, SA Baker, MS Sidhu… - Vaccine, 2011 - Elsevier
13-Valent pneumococcal conjugate vaccine (PCV13) administered as a 4-dose series in
infants, and as a toddler dose in infants previously vaccinated with PCV7 elicited …
infants, and as a toddler dose in infants previously vaccinated with PCV7 elicited …
Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given …
DM Kieninger, K Kueper, K Steul, C Juergens, N Ahlers… - Vaccine, 2010 - Elsevier
13-valent pneumococcal conjugate vaccine (PCV13) was compared to PCV7 in infants
administered 4 doses. For the 7 common serotypes, PCV13-and PCV7-elicited responses …
administered 4 doses. For the 7 common serotypes, PCV13-and PCV7-elicited responses …
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
S Senders, NP Klein, N Tamimi… - The Pediatric …, 2024 - journals.lww.com
Background: The 20-valent pneumococcal conjugate vaccine (PCV20) was developed to
extend pneumococcal disease protection beyond 13-valent PCV (PCV13). Methods: This …
extend pneumococcal disease protection beyond 13-valent PCV (PCV13). Methods: This …
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine
R Frenck Jr, A Thompson, SH Yeh… - The Pediatric …, 2011 - journals.lww.com
Background: The 7-valent pneumococcal conjugate vaccine (PCV7) has proven highly
effective in preventing diseases caused by Streptococcus pneumoniae; however, in some …
effective in preventing diseases caused by Streptococcus pneumoniae; however, in some …
Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 …
MW Simon, R Bataille, NS Caldwell… - Human Vaccines & …, 2023 - Taylor & Francis
Use of pneumococcal conjugate vaccines (PCVs) has led to substantial reductions in the
global burden of pediatric pneumococcal disease. Expansion of serotype coverage has …
global burden of pediatric pneumococcal disease. Expansion of serotype coverage has …
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan
LM Huang, TY Lin, C Juergens - Vaccine, 2012 - Elsevier
Immunogenicity and safety of 13-valent and 7-valent pneumococcal conjugate vaccines
(PCV13; PCV7) were compared in Taiwanese children. In this double-blind, multicenter …
(PCV13; PCV7) were compared in Taiwanese children. In this double-blind, multicenter …
[HTML][HTML] A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants
Y Ishihara, M Fukazawa, S Enomoto… - International Journal of …, 2024 - Elsevier
Objectives Safety and immunogenicity evaluation of a 4-dose series with 20-valent
pneumococcal conjugate vaccine (PCV20). Methods This phase 3, double-blind study …
pneumococcal conjugate vaccine (PCV20). Methods This phase 3, double-blind study …
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada
OG Vanderkooi, DW Scheifele, D Girgenti… - The Pediatric …, 2012 - journals.lww.com
Background: The global distribution of pneumococcal disease and emergence of
nonvaccine pneumococcal serotypes prompted the development of a 13-valent …
nonvaccine pneumococcal serotypes prompted the development of a 13-valent …
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine compared with 7-valent pneumococcal conjugate vaccine among healthy infants in China
F Zhu, Y Hu, J Li, Q Ye, MM Young Jr… - The Pediatric …, 2016 - journals.lww.com
Background: Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine
(PCV13) were compared with 7-valent pneumococcal conjugate vaccine (PCV7) in Chinese …
(PCV13) were compared with 7-valent pneumococcal conjugate vaccine (PCV7) in Chinese …